RxDoctor Payments Data

Marina Silveira, MD

Internal Medicine · New Haven, CTNPI 1831163526

Payments from drug & device makers

What this record shows

That places this record below the midpoint for internal medicine clinicians in CT, where the typical reported total is $124.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$406,451in research payments, 2019–2025

Across 113 payments — averaging $3596.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gilead$243K
  • Ipsen Pharma SAS$88K
  • Ipsen Bioscience Inc.$51K
  • Novartis$23K
  • Pfizer$585

How this compares

$0 in reported general payments places this provider in the 20th percentile of 2,067 internal medicine providers in Connecticut.

See all internal medicine providers in Connecticut

Medicare billing

Part B allowed, 2024
$31,547
Medicare patients
129
Services billed
225

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ursodiol169$40,523
XifaxanRifaximin12$38,578
Azathioprine56$3,647
Mycophenolate Mofetil28$2,353
Fenofibrate32$822
CholestyramineCholestyramine (With Sugar)11$502
Carvedilol23$474
Omeprazole22$275
Spironolactone20$150
Prednisone11$106

Paid to pharmacies, not to this prescriber.

Other internal medicine in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →